awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q22252598-16D1796B-C6C4-4B36-A646-D9875990BC8A
Q22252598-16D1796B-C6C4-4B36-A646-D9875990BC8A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q22252598-16D1796B-C6C4-4B36-A646-D9875990BC8A
Cost-Effectiveness of Disease-Modifying Therapies in Multiple Sclerosis
P2860
Q22252598-16D1796B-C6C4-4B36-A646-D9875990BC8A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q22252598-16D1796B-C6C4-4B36-A646-D9875990BC8A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
11eab934057b5b64c39b3d945a29bb4df996b3a9
P2860
NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial.